CAIRE Inc. acquires Spirosure, broadens product portfolio


CAIRE Inc. has acquired Spirosure, Inc. to expand CAIRE’s portfolio into the diagnostic segment of respiratory care.

Spirosure is a California-based developer and manufacturer of an innovative technology for measuring fractional exhaled nitric oxide, which is a key indicator of allergic inflammation in asthmatic patients. 

Spirosure will operate as a division of Georgia, US-based CAIRE to be known as CAIRE Diagnostics Inc.

... to continue reading you must be subscribed

Subscribe Today

Paywall Asset Header Graphic

To access hundreds of features, subscribe today! At a time when the world is forced to go digital more than ever before just to stay connected, discover the in-depth content our subscribers receive every month by subscribing to gasworld.

Please wait...